Get started
Author

Michael Silverman

Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing
2012 · Dea Shahinas, Michael Silverman, et al. · mBio · 191
Breaking down the gut microbiome composition in multiple sclerosis
2016 · Adrian Budhram, Seema Parvathy, et al. · Multiple Sclerosis Journal · 51
PDF
Infectious diseases specialist management improves outcomes for outpatients diagnosed with cellulitis in the emergency department: a double cohort study
2017 · Shilpa R. Jain, Seyed M. Hosseini-Moghaddam, et al. · Diagnostic Microbiology and Infectious Disease · 28
PDF
Evaluation of New Anti-Infective Drugs for the Treatment of Syphilis
1992 · Allan R. Ronald, Michael Silverman, et al. · Clinical Infectious Diseases · 24
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial
2024 · Jessica R. Allegretti, Colleen R. Kelly, et al. · Gastroenterology · 23
PDF
Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome
2021 · Natalie Farha, Jennifer Hrabe, et al. · Gastrointestinal Endoscopy · 21
S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial
2021 · Sahil Khanna, Colleen R. Kelly, et al. · The American Journal of Gastroenterology · 19
Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?
2017 · Ryan M Chanyi, Laura Craven, et al. · SAGE Open Medicine · 14
Older patients are significantly more likely to have colon ischaemia‐associated conditions that are chronic and complex
2019 · Michael Silverman, Olga C. Aroniadis, et al. · Alimentary Pharmacology & Therapeutics · 9
Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria
2017 · Laura J. Craven, Michael Silverman, et al. · Annals of Translational Medicine · 9
PDF
Bilateral Cavernous Sinus Thrombosis in Lemierre’s Syndrome
2017 · Adrian Budhram, Basavaraj Shettar, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 6
PDF
S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection
2021 · Jessica R. Allegretti, Colleen R. Kelly, et al. · The American Journal of Gastroenterology · 5
LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor
2019 · Kevin W Garey, Kevin W Garey, et al. · Open Forum Infectious Diseases · 3
PDF
Use of dalbavancin in treatment of acute bacterial skin and skin structure infections: Case series from a Canadian perspective
2025 · Wayne Leung, Janhavi Bhalla, et al. · Journal of the Association of Medical Microbiology and Infectious Disease Canada · 2
PDF
Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection
2023 · Matthew Sims, Michael Silverman, et al. · Antimicrobial Stewardship & Healthcare Epidemiology · 2
PDF
S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection
2021 · Jessica R. Allegretti, Colleen R. Kelly, et al. · The American Journal of Gastroenterology · 2
A single‐ and multiple‐ascending dose study to evaluate the safety and pharmacokinetics of oral PU‐AD, an epichaperome inhibitor to treat Alzheimer’s disease
2020 · Michael Silverman, Barbara Wallner, et al. · Alzheimer s & Dementia · 2
PDF
Su1553 - Impact of Fecal Microbial Transplantation on Intestinal Permeability in Non Alcoholic Fatty Liver Disease
2018 · Seema Nair Parvathy, Melanie D. Beaton, et al. · Gastroenterology · 2
S0142 Antibiotics Do Not Improve Outcomes in Colon Ischemia (CI) - Results from a Large Retrospective Multi-Center Study
2020 · Paul Feuerstadt, Karthik Gnanapandithan, et al. · The American Journal of Gastroenterology · 1
A cluster of non-tuberculosis mycobacterial infections in patients with connective tissue diseases
2020 · Andreu Fernández-Codina, Michael Silverman, et al. · Medicina Clínica (English Edition) · 1
Analysis of the music-based interventions and chronic obstructive pulmonary disease literature by the music-based intervention reporting guidelines
2026 · Lana Y. Lee, Michael J. Silverman · The Arts in Psychotherapy
701. An Open-label Phase 2a Study of Ibezapolstat, a Unique Gram-positive Selective Spectrum (GPSS) Antibiotic, for Patients with Clostridioides difficile Infection
2021 · Kevin W Garey, Khurshida Begum, et al. · Open Forum Infectious Diseases
S0235 Effect of Chronic Kidney Disease on Short-Term Morbidity and Mortality in Patients With Colon Ischemia
2020 · Riana B. Jumamil, Joann Kwah, et al. · The American Journal of Gastroenterology
S0241 American College of Gastroenterology (ACG) Guidelines for Classification of Severity in Colonic Ischemia (CI) Is Useful in Predicting Mortality and Other Adverse Outcomes
2020 · Karthik Gnanapandithan, Olga Aroniadis, et al. · The American Journal of Gastroenterology
Editorial: older patients are significantly more likely to have colon ischaemia‐associated conditions that are chronic and complex—authors' reply
2019 · Michael Silverman, Olga C. Aroniadis, et al. · Alimentary Pharmacology & Therapeutics
PDF
Works count: 31
Citation count: 415
H-index: 9
I10-index: 8
Year
Topic
Type